Search clinical trials for: Contrast agent BR

Total 310871 results

University of Cologne

Completed

Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury (RenPro-II-WINE)

Chronic Renal Failure/ Kidney Disease | Contrast-medium Induced Acute Kidney Injury

Germany
Samsung Medical Center

Withdrawn

Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease

Pulmonary Non-tuberculous Mycobacterial Lung Disease

Korea, Republic of
MDDX LLC
GE Healthcare

Completed

Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning (ICARUS)

Coronary Arteriosclerosis

Canada, United States
Ospedale Misericordia e Dolce

Completed

Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction

Acute Kidney Injury

Italy
Hamilton Health Sciences Corporation

Completed

Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization

Kidney Failure

Canada
Bracco Diagnostics, Inc

Completed

Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)

Renal Insufficiency

United States
Capital Medical University

Unknown

Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis

Stenosis

China
Federal University of São Paulo
InCor Heart Institute; Hospital das Forças Armadas, Brazil

Completed

Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury

Acute Renal Failure

Brazil
Maastricht University Medical Center

Completed

Gadofosveset for Axillary Staging in Breast Cancer Patients

Breast Neoplasms

Netherlands
M.D. Anderson Cancer Center

Completed

Measuring Non-Enhancing Glioblastoma Progression

Glioblastoma | Brain Tumor

United States
British Columbia Cancer Agency
Canadian Institutes of Health Research (CIHR)

Terminated

Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer

Cervix Cancer

Canada
Bracco Diagnostics, Inc

Completed

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries (VALUE)

Carotid, Aortic, Renal or Peripheral Artery Disease

China
Institut Bergonié

Completed

MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer

Breast Cancer

France
Gruppo Italiano per lo Studio della Diverticolite...

Completed

Italian Study Group on Complicated Diverticulosis (GISDIC)

Diverticulitis

Italy
University of California, Irvine
Janssen, LP

Unknown

Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning

Schizophrenia

United States
Hospital do Coracao
Medley Pharmaceutical Industry SA

Completed

The Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)

Acute Kidney Failure

Brazil
Pfizer

Completed

Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

Pneumonia, Ventilator-Associated

United States, Puerto Rico
Grupo de Cirurgia Vascular

Completed

Use of Oxybutynin to Treat Axillary Hyperhidrosis

Axillary Hyperhidrosis | Osmidrosis

Brazil
Bayer

Completed

Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

Peripheral Vascular Diseases

Germany, Switzerland, Argentina, Austria, Mexico, Brazil
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Completed

PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION

Kidney Failure, Acute

Switzerland, Italy
Bracco Diagnostics, Inc

Completed

Follow-up Study to Previous CARE Trial

Moderate to Severe Chronic Kidney Disease

United States
Amersham Buchler, GmbH & Co KG
The Cleveland Clinic; Beacon Bioscience, Inc.; CRL, Medinet Europe, Breda, The... and other collaborators

Completed

A Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging (MR-IMPACT-II)

Coronary Artery Disease
Arpida AG

Terminated

Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia

Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

Coronary Artery Disease

United States
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease

Coronary Artery Disease

United States
Point Biomedical

Terminated

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease (POINT II)

Coronary Artery Disease

United States
Point Biomedical

Completed

Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease

Coronary Artery Disease | Healthy

United States
National Institutes of Health Clinical Center (CC)

Completed

MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis

Multiple Sclerosis

United States
National Institute of Neurological Disorders and...

Completed

Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer

Breast Neoplasms

United States
Bracco Diagnostics, Inc

Completed

A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain (ENHANCE)

Brain Pathology

United States
University Hospital, Tours

Completed

A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions

Breast Tumors

France
Technical University of Munich

Completed

Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy (ATHENS)

Kidney Diseases | Renal Failure | Adverse Effects | Contrast Induced Nephropathy

Germany
University Hospital, Tours

Completed

Ultrasound and Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response

Breast Cancer

France
University of Sao Paulo

Completed

Visual Function Changes After Intraocular Pressure Reduction

Glaucoma
Acusphere

Completed

Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF

Chronic Obstructive Pulmonary Disease | Congestive Heart Failure

United States
Bracco Diagnostics, Inc

Completed

A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography

CIN

United States
University Hospital Muenster

Unknown

Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients

Epilepsy | Dizziness | Headache

Germany
The First Affiliated Hospital with Nanjing Medical...
Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Not yet recruiting

To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer

Breast Cancer | HR+/HER2- Breast Cancer
GlaxoSmithKline
iTeos Therapeutics

Recruiting

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Lung Cancer, Non-Small Cell

Argentina, Belgium, Brazil, Canada, Finland, Germany, Italy, Japan, Mexico, Panama, Spain, Taiwan, Turkey, Poland, Netherlands, Korea, Republic of, France, Greece, Bulgaria, Croatia, Czechia, Estonia, Hong Kong, Hungary, India, Philippines, Portuga... and more
Boston Children's Hospital

Not yet recruiting

Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine

Post Operative Pain | Spinal Fusion

United States
Zunyi Medical College

Recruiting

A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy

HER-2 Positive Advanced Breast Cancer

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study (CORTICONEHI)

Neuroendocrine Cell Hyperplasia of Infancy

France
Zaparackas and Knepper LTD
Northwestern University Feinberg School of Medicine

Not yet recruiting

RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β

Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline

United States
Institut Cancerologie de l'Ouest

Not yet recruiting

Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases (BRADI)

Brain Metastases | Radionecrosis of Brain

France
Merck Sharp & Dohme LLC

Not yet recruiting

Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Esophageal Cancer | Esophageal Neoplasms | Gastroesophageal Adenocarcinoma | Gastroesophageal Junction
AstraZeneca

Not yet recruiting

A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma (BAIYUN)

Asthma

China
University of California, San Francisco
Merck Sharp & Dohme LLC; Astellas Pharma Inc

Not yet recruiting

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Bladder Cancer | Muscle-Invasive Bladder Carcinoma | Stage IIIA Bladder Cancer AJCC v8 | Stage II Bladder Cancer AJCC v8

United States
Yuanquan Yang

Not yet recruiting

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

Advanced Malignant Solid Neoplasm | Hematopoietic and Lymphatic System Neoplasm

United States
Anaveon AG
Merck Sharp & Dohme LLC

Not yet recruiting

A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)

Advanced Solid Tumor
Tuen Mun Hospital

Not yet recruiting

Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study

Osteoporosis | Glucocorticoids Toxicity

China

3

Subscribe